Alpha Cognition Shares Outstanding 2020-2024 | ACOG
Alpha Cognition shares outstanding from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Alpha Cognition Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
94 |
| 2022 |
68 |
| 2021 |
53 |
| 2020 |
43 |
| 2019 |
31 |
Alpha Cognition Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-06-30 |
150 |
| 2024-03-31 |
144 |
| 2023-12-31 |
94 |
| 2023-09-30 |
97 |
| 2023-06-30 |
95 |
| 2023-03-31 |
78 |
| 2022-12-31 |
68 |
| 2022-09-30 |
68 |
| 2022-06-30 |
68 |
| 2022-03-31 |
68 |
| 2021-12-31 |
53 |
| 2021-09-30 |
52 |
| 2021-06-30 |
52 |
| 2021-03-31 |
44 |
| 2020-12-31 |
43 |
| 2020-09-30 |
43 |
| 2020-06-30 |
43 |
| 2020-03-31 |
43 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
